Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
J Clin Med
2020 May 15;95:. doi: 10.3390/jcm9051494.
Show Gene links
Show Anatomy links
Marine Polyhydroxynaphthoquinone, Echinochrome A: Prevention of Atherosclerotic Inflammation and Probable Molecular Targets.
Artyukov AA
,
Zelepuga EA
,
Bogdanovich LN
,
Lupach NM
,
Novikov VL
,
Rutckova TA
,
Kozlovskaya EP
.
Abstract
The effect of low doses of echinochrome A (EchA), a natural polyhydroxy-1,4-naphthoquinone pigment from the sea urchin Scaphechinus mirabilis, has been studied in clinical trials, when it was used as an active substance of the drug Histochrome® and biologically active supplement Thymarin. Several parameters of lipid metabolism, antioxidant status, and the state of the immune system were analyzed in patients with cardiovascular diseases (CVD), including contaminating atherosclerosis. It has been shown that EchA effectively normalizes lipid metabolism, recovers antioxidant status and reduces atherosclerotic inflammation, regardless of the method of these preparations' administrations. Treatment of EchA has led to the stabilization of patients, improved function of the intracellular matrix and decreased epithelial dysfunction. The increased expression of surface human leukocyte antigen DR isotype (HLA-DR) receptors reflects the intensification of intercellular cooperation of immune cells, as well as an increase in the efficiency of processing and presentation of antigens, while the regulation of CD95 + expression levels suggests the stimulation of cell renewal processes. The immune system goes to a different level of functioning. Computer simulations suggest that EchA, with its aromatic structure of the naphthoquinone nucleus, may be a suitable ligand of the cytosolic aryl cell receptor, which affects the response of the immune system and causes the rapid expression of detoxification enzymes such as CYP and DT diaphorase, which play a protective role with CVD. Therefore, EchA possesses not only an antiradical effect and antioxidant activity, but is also a SOD3 mimetic, producing hydrogen peroxide and controlling the expression of cell enzymes through hypoxia-inducible factors (HIF), peroxisome proliferator-activated receptors (PPARs) and aryl hydrocarbon receptor (AhR).
Figure 1. Structure of echinochrome A (EchA), K2 and C vitamins.
Figure 2. Indicators of lipid metabolism in patients of the control-volunteers and the main groups (before and after treatment with Histochrome, m ± SD-Standard Deviation). Abbreviations: Cholesterol: cholesterol, mmol/L; TAG: triglycerides, mmol/l; VLDL: cholesterol of very-low-density lipoproteins, mmol/L; LDL: cholesterol of low-density lipoproteins, mmol/L; HDL: cholesterol of high-density lipoproteins, mol/L; APOA1: apolipoprotein A1, g/L; AIP: (total cholesterol − HDL)/HDL. * differences with the control group were reliable at p < 0.05; ** differences before and after treatment were reliable at p < 0.05.
Figure 3. Relative content of lymphocytes expressing the activation and the differentiation markers in the blood in patients of the control-volunteers and experimental groups (before and after treatment with Histochrome, m ± SD). * differences with the control group were reliable at p < 0.05; ** differences before and after treatment were reliable at p < 0.05.
Figure 4. Spatial structural model of EchA complex with the ligand binding domain of human aryl hydrocarbon receptor (huAhR LBD). (A) Ribbon diagram of a structural model of EchA complex with huAhR LBD; EchA molecule is represented as ball and stick, colored according to elements; the hydrophobic cavity surface around the EchA is colored by aromaticity; residues involved in EchA binding represented as sticks and colored by elements. (B) A scheme of EchA intermolecular non-covalent interactions in complex with huAhR LBD; intermolecular non-covalent interactions are shown as dashed lines, and direct hydrogen bonds are colored in green; water-mediated hydrogen bonds in blue; π- alkyl, π-π stacked, and π-π T-shaped interactions in magenta.
Afanasiev,
[ATP-preserving effect of histochrome during acute myocardial ischemia in patients with ischemic heart disease].
1997, Pubmed
Afanasiev,
[ATP-preserving effect of histochrome during acute myocardial ischemia in patients with ischemic heart disease].
1997,
Pubmed
Agafonova,
Assessment of Nephroprotective Potential of Histochrome during Induced Arterial Hypertension.
2015,
Pubmed
Backlund,
Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation.
2004,
Pubmed
Ball,
Hydrogen Peroxide Triggers a Dual Signaling Axis To Selectively Suppress Activated Human T Lymphocyte Migration.
2017,
Pubmed
Bandeali,
High-density lipoprotein and atherosclerosis: the role of antioxidant activity.
2012,
Pubmed
Barouki,
The aryl hydrocarbon receptor system.
2012,
Pubmed
Beischlag,
The aryl hydrocarbon receptor complex and the control of gene expression.
2008,
Pubmed
Beulens,
High dietary menaquinone intake is associated with reduced coronary calcification.
2009,
Pubmed
Bikadi,
Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock.
2009,
Pubmed
Binder,
The role of natural antibodies in atherogenesis.
2005,
Pubmed
Bisson,
Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands.
2009,
Pubmed
Bonati,
Molecular modeling of the AhR structure and interactions can shed light on ligand-dependent activation and transformation mechanisms.
2017,
Pubmed
Busquets-Cortés,
Effects of Millimolar Steady-State Hydrogen Peroxide Exposure on Inflammatory and Redox Gene Expression in Immune Cells from Humans with Metabolic Syndrome.
2018,
Pubmed
Chatrou,
Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists.
2012,
Pubmed
Cherubini,
Role of antioxidants in atherosclerosis: epidemiological and clinical update.
2005,
Pubmed
Dumitriu,
The role of T and B cells in atherosclerosis: potential clinical implications.
2011,
Pubmed
Erkkilä,
Vitamin K intake and atherosclerosis.
2008,
Pubmed
Eswar,
Comparative protein structure modeling using MODELLER.
2007,
Pubmed
Fenyo,
The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis.
2013,
Pubmed
Fukunaga,
Identification of functional domains of the aryl hydrocarbon receptor.
1995,
Pubmed
Gale,
Antioxidant vitamin status and carotid atherosclerosis in the elderly.
2001,
Pubmed
Galkina,
Immune and inflammatory mechanisms of atherosclerosis (*).
2009,
Pubmed
Gerber,
MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry.
1995,
Pubmed
Goldstone,
The chemical defensome: environmental sensing and response genes in the Strongylocentrotus purpuratus genome.
2006,
Pubmed
,
Echinobase
Goryo,
Identification of amino acid residues in the Ah receptor involved in ligand binding.
2007,
Pubmed
Hanieh,
Toward understanding the role of aryl hydrocarbon receptor in the immune system: current progress and future trends.
2014,
Pubmed
Hansson,
The immune response in atherosclerosis: a double-edged sword.
2006,
Pubmed
Hansson,
Inflammation and atherosclerosis.
2006,
Pubmed
Hansson,
The immune system in atherosclerosis.
2011,
Pubmed
Hirano,
In silico analysis of the interaction of avian aryl hydrocarbon receptors and dioxins to decipher isoform-, ligand-, and species-specific activations.
2015,
Pubmed
Irrcher,
Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells.
2009,
Pubmed
Jaeger,
Role of Aryl Hydrocarbon Receptor in Circadian Clock Disruption and Metabolic Dysfunction.
2016,
Pubmed
Jaronen,
Immunological Relevance of the Coevolution of IDO1 and AHR.
2014,
Pubmed
Jeong,
Echinochrome a increases mitochondrial mass and function by modulating mitochondrial biogenesis regulatory genes.
2014,
Pubmed
,
Echinobase
Key,
Principles of ligand binding within a completely buried cavity in HIF2alpha PAS-B.
2009,
Pubmed
Klotz,
1,4-naphthoquinones: from oxidative damage to cellular and inter-cellular signaling.
2014,
Pubmed
Kruger-Zeitzer,
Effects of 1,4-naphthoquinone derivatives on red blood cell metabolism.
1990,
Pubmed
Kwak,
Statins as a newly recognized type of immunomodulator.
2000,
Pubmed
Lebedev,
[Acidity and interaction with superoxide anion radical of echinochrome and its structural analogs].
1999,
Pubmed
,
Echinobase
Lebedev,
Interaction of natural polyhydroxy-1,4-naphthoquinones with superoxide anion-radical.
1999,
Pubmed
Lebedev,
How do calcium ions induce free radical oxidation of hydroxy-1,4-naphthoquinone? Ca2+ stabilizes the naphthosemiquinone anion-radical of echinochrome A.
2003,
Pubmed
,
Echinobase
Li,
Oxidative stress in vascular disease and its pharmacological prevention.
2013,
Pubmed
Libby,
Inflammation in atherosclerosis.
NULL,
Pubmed
Lusis,
Atherosclerosis.
2000,
Pubmed
Martin,
Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.
2001,
Pubmed
Marx,
PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
2002,
Pubmed
McGuire,
Definition of a dioxin receptor mutant that is a constitutive activator of transcription: delineation of overlapping repression and ligand binding functions within the PAS domain.
2001,
Pubmed
McMillan,
Role of oxidant stress in lawsone-induced hemolytic anemia.
2004,
Pubmed
Motto,
New aryl hydrocarbon receptor homology model targeted to improve docking reliability.
2011,
Pubmed
Moura-Alves,
AhR sensing of bacterial pigments regulates antibacterial defence.
2014,
Pubmed
Navab,
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
2004,
Pubmed
Niessner,
Dendritic cells in atherosclerotic disease.
2010,
Pubmed
Niki,
Antioxidants and atherosclerosis.
2004,
Pubmed
Pandini,
Detection of the TCDD binding-fingerprint within the Ah receptor ligand binding domain by structurally driven mutagenesis and functional analysis.
2009,
Pubmed
Perkins,
A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain.
2014,
Pubmed
Pernomian,
Current basis for discovery and development of aryl hydrocarbon receptor antagonists for experimental and therapeutic use in atherosclerosis.
2015,
Pubmed
Perry,
B cell subsets in atherosclerosis.
2012,
Pubmed
Perry,
Ca2+-stimulated production of H2O2 from naphthoquinone oxidation in Arbacia eggs.
1981,
Pubmed
,
Echinobase
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Salonen,
Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study.
2003,
Pubmed
Schurgers,
Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization.
2013,
Pubmed
Seneviratne,
Toll-like receptors and macrophage activation in atherosclerosis.
2012,
Pubmed
Seok,
Structural hierarchy controlling dimerization and target DNA recognition in the AHR transcriptional complex.
2017,
Pubmed
Siekmeier,
Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations.
2007,
Pubmed
Sodergren,
The genome of the sea urchin Strongylocentrotus purpuratus.
2006,
Pubmed
,
Echinobase
Stocker,
Role of oxidative modifications in atherosclerosis.
2004,
Pubmed
Subramanian,
Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.
2013,
Pubmed
Suhara,
Hydrogen peroxide induces up-regulation of Fas in human endothelial cells.
1998,
Pubmed
Tedgui,
Cytokines in atherosclerosis: pathogenic and regulatory pathways.
2006,
Pubmed
Tsibul'skiĭ,
[The comparative study of the medical action of lyuteolin, rosmarinic acid and echinochrom A at experimental stress-induced cardiopathology].
2011,
Pubmed
Tsybul'skiĭ,
[Enhancing the immunogenic activity of influvac vaccine in the use of adjuvant TI complexes modified by echinochrome A].
2012,
Pubmed
,
Echinobase
Waring,
Cell death induced by the Fas/Fas ligand pathway and its role in pathology.
1999,
Pubmed
Ye,
The Aryl Hydrocarbon Receptor Preferentially Marks and Promotes Gut Regulatory T Cells.
2017,
Pubmed
Yi,
Aryl Hydrocarbon Receptor: A New Player of Pathogenesis and Therapy in Cardiovascular Diseases.
2018,
Pubmed
Zhu,
NAD(P)H: quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions.
2012,
Pubmed